How creative thinking can turn our heads
Bullish or bearish?
For the longest time many folks have been rather bearish when it comes to drugging seemingly intractable targets in oncology.
It doesn’t always have to be this way though.
Lately, our perceptions have been slowly changing over time as scientists find new ways to tackle the R&D equivalent of the north face of the Eiger for the first time without modern technological advances.
The annual meeting of the American Association for Cancer Research (AACR) is often a good place to start when it comes to hearing about novel approaches to turn our heads.
In this report, we take a look at some inspired thinking with a fresh look at the science behind what could become a new target to aim at…
To learn more from our latest oncology expert interview and get a heads up on key cancer research insights, subscribers can log-in or you can click to gain access to BSB Premium Content.
This content is restricted to subscribers
